Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Jeannina A, Smith"'
Autor:
Hanna L. Kleiboeker, PharmD, BCTXP, Jillian L. Descourouez, Emily M. Garcia, Olivia G. Huber, Ravi Dhingra, Erin Lowery, Didier A. Mandelbrot, MD, Jeannina A. Smith, Christopher M. Saddler, Margaret R. Jorgenson
Publikováno v:
JHLT Open, Vol 4, Iss , Pp 100063- (2024)
Despite the availability of potent antiviral therapy and increasingly long prophylaxis courses, cytomegalovirus (CMV) infection continues to negatively affect outcomes after cardiothoracic transplant (CT). CMV antiviral stewardship (AVS) represents a
Externí odkaz:
https://doaj.org/article/31efc6f43e5443fd97e9fc137cc84a39
Autor:
Emily E. Zona, Mina L. Gibes, Asha S. Jain, Juan S. Danobeitia, Jacqueline Garonzik-Wang, Jeannina A. Smith, Didier A. Mandelbrot, Sandesh Parajuli
Publikováno v:
Critical Care Research and Practice, Vol 2024 (2024)
Background. Kidney transplant recipients (KTRs) are a vulnerable immunocompromised population at risk of severe COVID-19 disease and mortality after SARS-CoV-2 infection. We sought to characterize the post-infection sequelae in KTRs at our center. Me
Externí odkaz:
https://doaj.org/article/84430add40c944499030003a3fe567c8
Autor:
Margaret R. Jorgenson, PharmD, Sandesh Parajuli, MBBS, Nicholas Marka, PhD, Glen E. Leverson, PhD, Jeannina A. Smith, MD, Didier A. Mandelbrot, MD, Jon S. Odorico, MD
Publikováno v:
Transplantation Direct, Vol 7, Iss 6, p e704 (2021)
Backgrounds. Cytomegalovirus (CMV) negatively affects transplant outcomes. The current geographic distribution of CMV risk within the US has not been described. Methods. CMV serostatus of donors and recipients in each US state were collected from the
Externí odkaz:
https://doaj.org/article/8d6c233b6bc34d6288b6795c156bda55
Autor:
Margaret R, Jorgenson, Jillian L, Descourouez, Lucas T, Schulz, Christopher M, Saddler, Jeannina A, Smith
Publikováno v:
Current Opinion in Organ Transplantation. 28:8-14
Despite the availability of potent antivirals, consensus guidelines and decades of research, cytomegalovirus (CMV) continues to be associated with negative outcomes after solid organ transplant. This has been attributed to postprophylaxis CMV infecti
Autor:
Hanna L. Kleiboeker, Jillian L. Descourouez, Lucas T. Schulz, Didier A. Mandelbrot, Jon S. Odorico, John P. Rice, Christopher M. Saddler, Jeannina A. Smith, Margaret R. Jorgenson
Publikováno v:
Annals of Pharmacotherapy. 57:597-608
Objective: To review the efficacy and safety of maribavir for management of cytomegalovirus (CMV) in solid organ transplant recipients. Data Sources: A literature search of PubMed and the Cochrane Controlled Trials Register (1960 to early July 2022)
Autor:
Emily Zona, Margaret Jorgenson, Sonam Dolma, Angelie Santos, Neetika Garg, Fahad Aziz, Maha Mohamed, Christopher M. Saddler, Jeannina A. Smith, Didier Mandelbrot, Sandesh Parajuli
Publikováno v:
Clinical Transplantation.
Autor:
Margaret R. Jorgenson, Hanna L. Kleiboeker, Brad C. Astor, Amy C. Gentry, Christopher M. Saddler, Jeannina A. Smith, Fahad Aziz, Didier Mandelbrot, Neetika Garg
Publikováno v:
Clinical transplantationREFERENCES.
Studies conducted in the northern United States found cytomegalovirus (CMV) disease after liver transplantation follows a seasonal pattern, with increased incidence in fall and winter. This has not been evaluated in kidney transplant recipients. Impr
Publikováno v:
Transplant Infectious Disease. 24
Autor:
Hanna L. Kleiboeker, Margaret R. Jorgenson, Glen E. Leverson, John P. Rice, Christopher M. Saddler, Jeannina A. Smith, David Al‐Adra
Publikováno v:
Transplant Infectious Disease. 24
To evaluate epidemiology, risk-factors, and outcomes of high-level (HL) cytomegalovirus (CMV) viremia in liver transplant recipients.Adult patients receiving a liver transplant between 1/1/2017 and 9/30/2020 were evaluated. Viral loads at University
Autor:
Margaret R. Jorgenson, Jillian L. Descourouez, Hanna Kleiboeker, Kerry Goldrosen, Lucas Schulz, John P. Rice, Jon S. Odorico, Didier A. Mandelbrot, Jeannina A. Smith, Christopher M. Saddler
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation SocietyREFERENCES. 24(5)
Antimicrobial stewardship programs (ASPs) are essential entities that promote the appropriate use of antimicrobials, leading to improved patient outcomes and reduced resistance. Application to the immunocompromised host is a natural progression for e